EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Peptide-Based PROTACs: Transitioning from Static Paradigm to a Dynamic Landscape within Targeted Protein Degradation

Xinchen Lu, Quanyin Hu iD

Bioconjugate Chemistry · 2026

DOI: 10.1021/acs.bioconjchem.6c00029 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Bioconjugate Chemistry, 2026. Verfasst von Xinchen Lu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin 53703, United States. Hauptthemen laut MEDLINE: Proteolysis, Peptides, Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS, NCI NIH HHS, University of Wisconsin-Madison.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteolysis-targeting chimeras (PROTACs) are becoming a powerful therapeutic strategy, enabling event-driven elimination of disease-causing proteins. While small-molecule PROTACs have advanced rapidly, their broader application is constrained by limited target scope, dependence on druggable binding pockets, and susceptibility to the hook effect. Peptide-based PROTACs (pPROTACs) have gained attention as a complementary platform, leveraging the specificity, modularity, and structural adaptability of conjugates to expand the range of degradable targets, including proteins traditionally considered undruggable. This review summarizes recent advances in classical pPROTAC design and conjugation strategies and highlights emerging nonclassic and deconstructive pPROTAC architectures that reassemble functional modules through supramolecular or genetic approaches. Further, bioPROTAC, as a protein-based degrader enabled by genetic encodability, is discussed. Together, these strategies position pPROTACs as an evolving class of targeted protein degradation agents that complement small-molecule approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteolysisPeptidesProteinsProteolysis Targeting ChimeraHumansAnimals

Substanzen

Proteolysis Targeting ChimeraPeptidesProteins

Autor:innen und Institutionen

  • Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin 53703, United States.
  • Carbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin 53703, United States.
  • Wisconsin Center for NanoBioSystems, School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin 53703, United States.

ORCID-Profile: Quanyin Hu

Förderung

  • NIBIB NIH HHS
  • NCI NIH HHS
  • University of Wisconsin-Madison

Zitieren

APA

Lu, X., & Hu, Q. (2026). Peptide-Based PROTACs: Transitioning from Static Paradigm to a Dynamic Landscape within Targeted Protein Degradation. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.6c00029

Vancouver

Lu X, Hu Q. Peptide-Based PROTACs: Transitioning from Static Paradigm to a Dynamic Landscape within Targeted Protein Degradation. Bioconjugate Chemistry. 2026. doi:10.1021/acs.bioconjchem.6c00029

BibTeX
@article{Lu2026,
  author = {Lu, Xinchen and Hu, Quanyin},
  title = {Peptide-Based PROTACs: Transitioning from Static Paradigm to a Dynamic Landscape within Targeted Protein Degradation},
  journal = {Bioconjugate Chemistry},
  year = {2026},
  doi = {10.1021/acs.bioconjchem.6c00029}
}
Kostenlos starten →